Humulin R Articles
Biotech Holdings files for DIAB II in Mexico
18 September 2001
Aradigm's AERx iDMS shown not to induce asthma
11 September 2001
Emisphere gets no lift from oral insulin data
10 September 2001
Czech drugmaker Spofa reduces losses
31 August 2001
GeneMedix highlights six-month progress
22 August 2001
Synaptic gains US patent on NPFF receptors
10 August 2001
GlaxoSmithKline warned over Avandia promotion by US FDA
6 August 2001
Stock Commentary - Europe
26 July 2001
Japan pharma stocks - week to July 23
25 July 2001
New drugs lift Lilly's 2nd qtr sales 16%
23 July 2001
Novartis and Novo join to market NN622
23 July 2001
New drugs lift Lilly's 2nd qtr sales 16%
20 July 2001
Update - Pfizer second-quarter net income leaps 31%
18 July 2001
Moldovan pharma market news
13 July 2001
Metabolex' lead drug enters the clinic
11 July 2001
Czech Spofa moves into the black again
11 July 2001
Australia: pharma industry contribution
6 July 2001
Emisphere starts oral insulin trial
6 July 2001
Sales of Xenical rise as new trial data reported
3 July 2001
New data with Novo, Aradigm's inhaled insulin
26 June 2001
Exubera outperforms injectable insulin
26 June 2001
New treatment for type 1 diabetes from Nutrition 21?
14 June 2001
Stock Commentary - Europe
7 June 2001
Dragon Pharma raises $8 million
7 June 2001
Amylin submits EU application for Symlin
5 June 2001
Novartis gets diabetes rights from Dr Reddy
30 May 2001
Aventis' Lantus launched in USA
24 May 2001
Inhaled insulin found safe after two years
24 May 2001
France "is failing on major disease care"
18 May 2001
Novo Nordisk sales climb 21%
9 May 2001
Genteric's insulin Gene Pill patented in USA
8 May 2001
40 million-euro private financing at DeveloGen
18 April 2001
Aventis insulin plant
9 April 2001
Lilly and Alkermes link up on inhaled insulin
5 April 2001
Generex opens expanded facility in Toronto
30 March 2001
Tokyo pharma stock market - week to March 26, 2001
27 March 2001
India raises prices of 14 formulations
20 March 2001
More Phase II data on Insmed's INS-1
28 February 2001
Novo Nordisk sales increase 27%
21 February 2001
FDA backs Avandia combo therapy
12 February 2001
Chinese pharma sales, other industry data
6 February 2001
Aradigm and Genentech drop development of improved CF drug
6 February 2001
Aventis resolves patent dispute with Novo Nordisk
1 February 2001
Zyprexa takes over as Eli Lilly's top seller
26 January 2001
Inhale hit by insulin risk rumor
17 January 2001
Michigan insurers must cover diabetes care
12 January 2001
Maxia enters into diabetes pact with J&J
5 January 2001
WHO views Serbian health, pharma crisis
3 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Novartis gains FDA OK for Starlix
28 December 2000
Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting
14 December 2000
US medics "not told of their drug errors '
13 December 2000
Amylin files Symlin NDA in USA
7 December 2000
Genset boosted by gene discovery
7 December 2000
Algeria's Saidal pulls out of insulin plant
7 December 2000
Alkermes' inhaled insulin shows promise in first clinical trial
28 November 2000
Mixed fortunes for Insmed products
27 November 2000
PPL Therapeutics moving into diabetes
14 November 2000
Epic unveils inhaled insulin technology
9 November 2000
New data show Xenical effective in treatment of diabetes
9 November 2000
Modernizing Merck KGaA looking to long-term growth from pharma
8 November 2000
US biotech pharma market to 2004
7 November 2000
Inhale pulls plans to buy Quadrant
6 November 2000
Amylin to start Ph III diabetes trial in 2001
6 November 2000
New products boost growth at Eli Lilly
20 October 2000
B-MS gets OK for Glucophage XR
18 October 2000
Fujisawa drops migraine compound
5 October 2000
Waratah raises $5.8 million in IPO
21 September 2000
Azerbaijan withdraws counterfeit drugs
22 August 2000
NICE verdict on SB's Avandia positive
18 August 2000
Chiron Corp to acquire PathoGenesis for $700 million in cash
15 August 2000
B-MS gains FDA OK for Glucovance
4 August 2000
Stock Commentary New York
3 August 2000
Isis finds NIDDM drug candidate
28 July 2000
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
